AJMC May 25, 2023
By Julia Bonavitacola

Although lack of routine testing and limitations to current diagnostic testing likely lead to underreporting of respiratory syncytial virus, RSV still poses a substantial economic burden.

Respiratory syncytial virus (RSV) was found to be an economic burden despite probable underreporting due to lack of routine testing, according to a study published in Journal of Medical Economics.

RSV is a seasonal virus that affects children and older adults. Approximately 470,000 adults 60 years and older have experienced an RSV-associated hospitalization and 33,000 in-hospital deaths areassociated with RSV. The management of acute respiratory infections has been previously estimated but did not report respiratory pathogen-specific management costs, the authors of the present study noted. This systematic literature review aimed to summarize...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Inside Anthony Fauci’s ‘On Call’: 9 health and science takeaways from the memoir of America’s most famous doctor
Former CDC director predicts bird flu pandemic
Here's What Is Wrong With the National Academies' Long COVID Definition
Minnesota Public Health Corps: A New Model For Building The Governmental Public Health Workforce
Adding a Sustainability Lens to Health Innovation Pilots

Share This Article